申请人:BRISTOL-MYERS SQUIBB COMPANY
公开号:US20170326247A1
公开(公告)日:2017-11-16
The drug component of an antibody-drug conjugate having a structure according to formula (II), where Ab, m, n, R
1
, R
2
, R
3
, R
4
, and R
5
are as defined in the application, exhibits unexpectedly improved stability.